C3 and hematoma: A study incorporating both clinical and murine data demonstrates that plasma C3 levels are elevated following ICH and correlate with hematoma volume and disease severity [61].C3-deficient mice exhibit reduced erythrocyte lysis, less brain injury, andimproved neurological recovery, indicating that targeting C3 may mitigateerythrocyte lysis post-ICH [62].